Example: marketing
New Zealand Data Sheet - Medsafe
New Zealand Data Sheet . Arrow - Ornidazole. Ornidazole Tablets 500 mg Antimicrobial agent for the treatment of infections due to trichomonads,
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Assessment report for tolperisone-containing …
www.ema.europa.eu1. Background information on the procedure 1.1. Referral of the matter to the CHMP On 15 July 2011, Germany triggered a referral under Article 31 of Directive 2001/83/EC.
Benefit summary 2018 - afhealth.co.za
www.afhealth.co.zaMEDICAL EVENT SCHEME BENEFIT Accommodation (hospital stay) and theatre fees 100% Scheme tariff. Take-home medicine 100% …
Problems of the Foreskin and Glans Penis - HKMA …
www.hkmacme.orgProblems of the Foreskin and Glans Penis Craig J. Huang, MD Conditions that affect the foreskin and glans penis that should be recognized by the
Why psychologists need to know about Lyme disease
www.lymediseaseaction.org.ukWhy psychologists need to know about Lyme disease Sarah L. Marzillier Clinical Psychology Forum 194 – February 2009 37 People …
Benefit summary 2018 - Pty Ltd
www.verimedptyltd.co.zaBeat1 Network option • Beat1, 2 and 3 also offer you the decision to lower your monthly contribu-tion in the form of a Network option. • The Network option provides you with a list of designated hospitals for
Discover our all new Critical Illness with Term …
www.aiglife.co.ukOur Critical Illness with Term Assurance covers all major conditions and more It is designed to cover death and the critical illness conditions that